Course curriculum

  • 1

    Respiratory

    • 13-valent pneumococcal (PCV13) vaccine in children (January 2020)

    • ACE-inhibitor-associated cough (March 2019)

    • Acute stridor in children - 2Qs (May 2020)

    • Asthma - diagnosis - 2Qs (January 2020)

    • Asthma - management - 2Qs (January 2020)

    • Asthma in young children - 2Qs (January 2020)

    • Asthma treatment - 3Qs (July 2018)

    • Bronchial thermoplasty (November 2019)

    • Chronic obstructive pulmonary disease - screening (November 2018)

    • Community-acquired pneumonia in adults - outpatient - 2Qs (January 2020)

    • Community-acquired pneumonia - inpatient - 2Qs (January 2020)

    • COPD and Roflumilast (September 2018)

    • Cough - postinfectious (January 2019)

    • Drowning (September 2019)

    • Drug-induced lung injury - 3Qs (November 2019)

    • Human metapneumovirus (January 2020)

    • Inhaled antimuscarinics - 2Qs (March 2020)

    • Eustachian tube dysfunction (November 2019)

    • Inhaled steroids in COPD (September 2019)

    • Latent tuberculosis - 2Qs (March 2019)

    • Lung cancer - 4Qs (January 2019)

    • Lung cancer in nonsmokers - 3Qs (September 2019)

    • Lung cancer screening (September 2018)

    • Mycobacterium Avium Complex - 2Qs (July 2019)

    • Obstructive disordered breathing in children - 2Qs (September 2020)

    • Respiratory Syncytial Virus - 2Qs (September 2019)

    • Rheumatoid arthritis-associated lung disease (July 2019)

    • Pleural effusion - 3Qs (May 2019)

    • Pulmonary embolism - diagnosis - 2Qs (May 2020)

    • Pulmonary embolism - incidental (January 2019)

    • Pulmonary embolism - subsegmental - 2Qs (March 2019)

    • Pulmonary sarcoidosis - 3Qs (May 2020)

    • Sleep apnea in children (May 2019)

    • Stridor in infants - 4Qs (May 2020)